December 2023 Newsletter
Posted on
Related content
India’s largest pharmaceutical company steps onto global mergers and acquisitions stage
Sun Pharmaceutical Industries signs to acquire Organon, reflecting India’s ongoing evolution from a source of growth to a global consolidator.
Major acquisition in US signals growing musculoskeletal innovation interest
US medical device company Zimmer Biomet has agreed to acquire Pacira’s Iovera device, signalling the growing value of musculoskeletal innovation.
Investor focus: MMC Ventures
In this Investor Focus, Macmillan Ventures explains how its impact investment approach supports early-stage health innovations, helping companies scale solutions that improve cancer care and tackle health inequalities.
